Search by Drug Name or NDC

    NDC 68001-0487-06 CAPECITABINE 150 mg/1 Details

    CAPECITABINE 150 mg/1

    CAPECITABINE is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BluePoint Laboratories. The primary component is CAPECITABINE.

    Product Information

    NDC 68001-0487
    Product ID 68001-487_fcfd1ff2-e3d6-dfff-e053-6394a90ababe
    Associated GPIs 21300005000320
    GCN Sequence Number 039780
    GCN Sequence Number Description capecitabine TABLET 150 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31611
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name CAPECITABINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name CAPECITABINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name BluePoint Laboratories
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202593
    Listing Certified Through 2024-12-31

    Package

    NDC 68001-0487-06 (68001048706)

    NDC Package Code 68001-487-06
    Billing NDC 68001048706
    Package 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68001-487-06)
    Marketing Start Date 2021-02-22
    NDC Exclude Flag N
    Pricing Information N/A